In the United States, commercial diagnostic tests—including in-vitro diagnostics, laboratory assays, and medical devices—generally require formal clearance or approval from the Food and Drug Administration (FDA) prior to being marketed and distributed for clinical use. The regulatory pathway depends on the device classification and associated risk levels, ensuring that diagnostic tools meet rigorous standards for analytical validity, safety, and clinical effectiveness.